Robert Arbogast

468 total citations
7 papers, 350 citations indexed

About

Robert Arbogast is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Robert Arbogast has authored 7 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 1 paper in Surgery and 1 paper in Molecular Biology. Recurrent topics in Robert Arbogast's work include Cardiac electrophysiology and arrhythmias (3 papers), Cardiac pacing and defibrillation studies (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Robert Arbogast is often cited by papers focused on Cardiac electrophysiology and arrhythmias (3 papers), Cardiac pacing and defibrillation studies (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Robert Arbogast collaborates with scholars based in France, Canada and United States. Robert Arbogast's co-authors include Martial G. Bourassa, William F. Hahne, Claude R. Benedict, Paul J. Schechter, Christian Brandt, Klaus D. Haegele, Monique Zreika, Michael G. Palfreyman and Joseph E. Wagner and has published in prestigious journals such as The American Journal of Medicine, The American Journal of Cardiology and Journal of Cardiovascular Pharmacology.

In The Last Decade

Robert Arbogast

6 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Arbogast France 6 244 139 134 49 37 7 350
C Libersa France 7 365 1.5× 140 1.0× 255 1.9× 24 0.5× 59 1.6× 10 515
David R. Mauritson United States 11 493 2.0× 81 0.6× 261 1.9× 34 0.7× 16 0.4× 14 557
E Lorentsen Norway 11 239 1.0× 138 1.0× 40 0.3× 27 0.6× 27 0.7× 23 395
A Circo Italy 6 337 1.4× 56 0.4× 74 0.6× 58 1.2× 21 0.6× 18 408
Masao Nagao Japan 10 428 1.8× 97 0.7× 302 2.3× 20 0.4× 49 1.3× 14 543
Ravinder M. Narang United States 6 249 1.0× 77 0.6× 88 0.7× 14 0.3× 15 0.4× 10 316
P Pucci Italy 7 361 1.5× 73 0.5× 221 1.6× 13 0.3× 14 0.4× 17 400
Pierre Y. Tilmant France 9 578 2.4× 178 1.3× 427 3.2× 42 0.9× 59 1.6× 13 683
Arthur E. Orlick United States 10 386 1.6× 104 0.7× 239 1.8× 29 0.6× 64 1.7× 10 502
Anthony Alvaro United States 8 289 1.2× 81 0.6× 205 1.5× 25 0.5× 13 0.4× 12 404

Countries citing papers authored by Robert Arbogast

Since Specialization
Citations

This map shows the geographic impact of Robert Arbogast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Arbogast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Arbogast more than expected).

Fields of papers citing papers by Robert Arbogast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Arbogast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Arbogast. The network helps show where Robert Arbogast may publish in the future.

Co-authorship network of co-authors of Robert Arbogast

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Arbogast. A scholar is included among the top collaborators of Robert Arbogast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Arbogast. Robert Arbogast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Benedict, Claude R., et al.. (1996). Single-Blind Study of the Effects of Intravenous Dolasetron Mesylate Versus Ondansetron on Electrocardiographic Parameters in Normal Volunteers. Journal of Cardiovascular Pharmacology. 28(1). 53–59. 87 indexed citations
2.
Arbogast, Robert, et al.. (1986). Acute Hemodynamic Effects of Piroximone (MDL 19,205) in Patients with Moderate Congestive Heart Failure: Comparison with Sodium Nitroprusside. Journal of Cardiovascular Pharmacology. 8(1). 82–89. 16 indexed citations
3.
Palfreyman, Michael G., Monique Zreika, Robert Arbogast, & Joseph E. Wagner. (1984). A method for measuring monoamine turnover in animals using an irreversible inhibitor of aromatic L-amino acid decarboxylase, DL-α-mono fluoromethyldopa. Journal of Pharmacological Methods. 11(4). 239–251. 8 indexed citations
4.
Arbogast, Robert, et al.. (1983). Hemodynamic Effects of MDL 17,043, a New Cardiotonic Agent, in Patients with Congestive Heart Failure. Journal of Cardiovascular Pharmacology. 5(6). 998–1004. 30 indexed citations
5.
Bourassa, Martial G. & Robert Arbogast. (1974). Reply. The American Journal of Cardiology. 34(5). 618–619. 1 indexed citations
6.
Arbogast, Robert & Martial G. Bourassa. (1973). Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms. The American Journal of Cardiology. 32(3). 257–263. 141 indexed citations
7.
Arbogast, Robert, et al.. (1973). Influence of aortocoronary saphenous vein bypass surgery on left ventricular volumes and ejection fraction. The American Journal of Medicine. 54(3). 290–296. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026